Safeguard Scientifics Co-Leads $21M Series C Financing for Putney

Safeguard Scientifics, Inc. (NYSE: SFE), today announced that it co-led a $21 million Series C financing for Putney, a Portland, ME-based specialty pharmaceutical company focused on providing high quality, cost-effective generic medicines for pets. Safeguard provided $10 million of financing; the additional capital was provided by NewSpring Health Capital and existing investors. Proceeds from the Series C will be used for product development and to enhance sales and marketing capabilities and additional operational and working capital needs.